NYU Langone has built an LLM research companion and medical advisor, and is pioneering what it calls AI-driven “precision medical education." ...
"We just cannot take this," one scientist said, as UMass Chan Medical School stands to lose about $41 million in annual ...
While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...
Celcuity's gedatolisib, a dual PI3K/mTOR inhibitor, shows promise in Phase 3 breast cancer trials. Click here to read an ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Solid Biosciences’ gene therapy uses a shortened version of the dystrophin protein, which is engineered to mimic the key ...
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...
⦁ The effects of angioplasty or stenting for people with deep vein thrombosis (DVT) are unclear. ⦁ Further larger studies are needed to determine whether angioplasty and stenting are safe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results